
### [MONDO:0001572](http://purl.obolibrary.org/obo/MONDO_0001572)
**Label:** leiomyoma

**Subclasses:** [MONDO:0000938](http://purl.obolibrary.org/obo/MONDO_0000938) (gastric leiomyoma), [MONDO:0002318](http://purl.obolibrary.org/obo/MONDO_0002318) (trachea leiomyoma), [MONDO:0001745](http://purl.obolibrary.org/obo/MONDO_0001745) (subserous uterine fibroid), [MONDO:0000934](http://purl.obolibrary.org/obo/MONDO_0000934) (laryngeal leiomyoma), [MONDO:0001664](http://purl.obolibrary.org/obo/MONDO_0001664) (submucous uterine fibroid), [MONDO:0003289](http://purl.obolibrary.org/obo/MONDO_0003289) (deep leiomyoma), [MONDO:0003288](http://purl.obolibrary.org/obo/MONDO_0003288) (bizarre leiomyoma), [MONDO:0007886](http://purl.obolibrary.org/obo/MONDO_0007886) (uterine corpus leiomyoma), [MONDO:0006312](http://purl.obolibrary.org/obo/MONDO_0006312) (myofibroma), [MONDO:0003285](http://purl.obolibrary.org/obo/MONDO_0003285) (fallopian tube leiomyoma), [MONDO:0003284](http://purl.obolibrary.org/obo/MONDO_0003284) (mediastinum leiomyoma), [MONDO:0021273](http://purl.obolibrary.org/obo/MONDO_0021273) (leiomyoma of ciliary body), [MONDO:0003287](http://purl.obolibrary.org/obo/MONDO_0003287) (central nervous system leiomyoma), [MONDO:0003286](http://purl.obolibrary.org/obo/MONDO_0003286) (extrahepatic bile duct leiomyoma), [MONDO:0003613](http://purl.obolibrary.org/obo/MONDO_0003613) (diffuse peritoneal leiomyomatosis), [MONDO:0003614](http://purl.obolibrary.org/obo/MONDO_0003614) (intravenous leiomyomatosis), [MONDO:0001634](http://purl.obolibrary.org/obo/MONDO_0001634) (bladder leiomyoma), [MONDO:0003458](http://purl.obolibrary.org/obo/MONDO_0003458) (uterine corpus adenofibroma), [MONDO:0006646](http://purl.obolibrary.org/obo/MONDO_0006646) (angioleiomyoma), [MONDO:0003299](http://purl.obolibrary.org/obo/MONDO_0003299) (colorectal leiomyoma), [MONDO:0001399](http://purl.obolibrary.org/obo/MONDO_0001399) (ureter leiomyoma), [MONDO:0003296](http://purl.obolibrary.org/obo/MONDO_0003296) (cellular leiomyoma), [MONDO:0003295](http://purl.obolibrary.org/obo/MONDO_0003295) (leiomyomatosis), [MONDO:0003298](http://purl.obolibrary.org/obo/MONDO_0003298) (vulvar leiomyoma), [MONDO:0003297](http://purl.obolibrary.org/obo/MONDO_0003297) (gallbladder leiomyoma), [MONDO:0003292](http://purl.obolibrary.org/obo/MONDO_0003292) (anus leiomyoma), [MONDO:0003291](http://purl.obolibrary.org/obo/MONDO_0003291) (leiomyoma cutis), [MONDO:0003294](http://purl.obolibrary.org/obo/MONDO_0003294) (pericardium leiomyoma), [MONDO:0003293](http://purl.obolibrary.org/obo/MONDO_0003293) (lung leiomyoma), [MONDO:0002934](http://purl.obolibrary.org/obo/MONDO_0002934) (intravascular angioleiomyoma), [MONDO:0001845](http://purl.obolibrary.org/obo/MONDO_0001845) (uterine corpus lipoleiomyoma), [MONDO:0001844](http://purl.obolibrary.org/obo/MONDO_0001844) (uterine corpus myxoid leiomyoma), [MONDO:0003703](http://purl.obolibrary.org/obo/MONDO_0003703) (uterine corpus leiomyomatosis), [MONDO:0003704](http://purl.obolibrary.org/obo/MONDO_0003704) (uterine corpus diffuse leiomyomatosis), [MONDO:0001846](http://purl.obolibrary.org/obo/MONDO_0001846) (uterine corpus bizarre leiomyoma), [MONDO:0001841](http://purl.obolibrary.org/obo/MONDO_0001841) (uterine corpus epithelioid leiomyoma), [MONDO:0003944](http://purl.obolibrary.org/obo/MONDO_0003944) (endobronchial leiomyoma), [MONDO:0003702](http://purl.obolibrary.org/obo/MONDO_0003702) (uterus intravascular leiomyomatosis), [MONDO:0004832](http://purl.obolibrary.org/obo/MONDO_0004832) (esophagus leiomyoma), [MONDO:0001843](http://purl.obolibrary.org/obo/MONDO_0001843) (uterus interstitial leiomyoma), [MONDO:0001842](http://purl.obolibrary.org/obo/MONDO_0001842) (uterine corpus dissecting leiomyoma), [MONDO:0003301](http://purl.obolibrary.org/obo/MONDO_0003301) (dartoic leiomyoma), [MONDO:0002057](http://purl.obolibrary.org/obo/MONDO_0002057) (breast leiomyoma), [MONDO:0002452](http://purl.obolibrary.org/obo/MONDO_0002452) (prostate leiomyoma), [MONDO:0003300](http://purl.obolibrary.org/obo/MONDO_0003300) (appendix leiomyoma), [MONDO:0002092](http://purl.obolibrary.org/obo/MONDO_0002092) (small intestine leiomyoma), [MONDO:0001536](http://purl.obolibrary.org/obo/MONDO_0001536) (vaginal leiomyoma), [MONDO:0004723](http://purl.obolibrary.org/obo/MONDO_0004723) (liver leiomyoma), [MONDO:0002222](http://purl.obolibrary.org/obo/MONDO_0002222) (urethra leiomyoma), [MONDO:0004125](http://purl.obolibrary.org/obo/MONDO_0004125) (rectum leiomyoma), [MONDO:0001092](http://purl.obolibrary.org/obo/MONDO_0001092) (colon leiomyoma), [MONDO:0004162](http://purl.obolibrary.org/obo/MONDO_0004162) (uterine corpus cellular leiomyoma), [MONDO:0004161](http://purl.obolibrary.org/obo/MONDO_0004161) (uterine corpus apoplectic leiomyoma), [MONDO:0006183](http://purl.obolibrary.org/obo/MONDO_0006183) (disseminated peritoneal leiomyomatosis), 

**Mapped go classes:** [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0060441](http://purl.obolibrary.org/obo/GO_0060441) (epithelial tube branching involved in lung morphogenesis), [GO:0060123](http://purl.obolibrary.org/obo/GO_0060123) (regulation of growth hormone secretion), [GO:0006284](http://purl.obolibrary.org/obo/GO_0006284) (base-excision repair), [GO:0033144](http://purl.obolibrary.org/obo/GO_0033144) (negative regulation of intracellular steroid hormone receptor signaling pathway), [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development), [GO:0090276](http://purl.obolibrary.org/obo/GO_0090276) (regulation of peptide hormone secretion), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0048712](http://purl.obolibrary.org/obo/GO_0048712) (negative regulation of astrocyte differentiation), [GO:0060428](http://purl.obolibrary.org/obo/GO_0060428) (lung epithelium development), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0060501](http://purl.obolibrary.org/obo/GO_0060501) (positive regulation of epithelial cell proliferation involved in lung morphogenesis), [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0051321](http://purl.obolibrary.org/obo/GO_0051321) (meiotic cell cycle), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0035019](http://purl.obolibrary.org/obo/GO_0035019) (somatic stem cell population maintenance), [GO:0003906](http://purl.obolibrary.org/obo/GO_0003906) (DNA-(apurinic or apyrimidinic site) lyase activity), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), [GO:2000773](http://purl.obolibrary.org/obo/GO_2000773) (negative regulation of cellular senescence), [GO:0021846](http://purl.obolibrary.org/obo/GO_0021846) (cell proliferation in forebrain), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0030261](http://purl.obolibrary.org/obo/GO_0030261) (chromosome condensation), [GO:0060613](http://purl.obolibrary.org/obo/GO_0060613) (fat pad development), [GO:0003680](http://purl.obolibrary.org/obo/GO_0003680) (AT DNA binding), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0000228](http://purl.obolibrary.org/obo/GO_0000228) (nuclear chromosome), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0040008](http://purl.obolibrary.org/obo/GO_0040008) (regulation of growth), [GO:0046426](http://purl.obolibrary.org/obo/GO_0046426) (negative regulation of JAK-STAT cascade), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:2000648](http://purl.obolibrary.org/obo/GO_2000648) (positive regulation of stem cell proliferation), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0071864](http://purl.obolibrary.org/obo/GO_0071864) (positive regulation of cell proliferation in bone marrow), [GO:0030178](http://purl.obolibrary.org/obo/GO_0030178) (negative regulation of Wnt signaling pathway), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), [GO:0010564](http://purl.obolibrary.org/obo/GO_0010564) (regulation of cell cycle process), 

**Class expressions from DL-Learner:**

- [GO:2000773](http://purl.obolibrary.org/obo/GO_2000773) (negative regulation of cellular senescence) 54.55%
- [GO:0090344](http://purl.obolibrary.org/obo/GO_0090344) (negative regulation of cell aging) 54.55%
- [GO:0060613](http://purl.obolibrary.org/obo/GO_0060613) (fat pad development) 54.55%
- [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development) 54.55%
- [GO:0048232](http://purl.obolibrary.org/obo/GO_0048232) (male gamete generation) 54.55%
- [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth) 54.55%
- [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development) 54.55%
- [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development) 54.55%
- [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development) 54.55%
- [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis) 54.55%
- [GO:0090344](http://purl.obolibrary.org/obo/GO_0090344) (negative regulation of cell aging) and [GO:2000772](http://purl.obolibrary.org/obo/GO_2000772) (regulation of cellular senescence) 54.55%
- [GO:0080135](http://purl.obolibrary.org/obo/GO_0080135) (regulation of cellular response to stress) and [GO:0090344](http://purl.obolibrary.org/obo/GO_0090344) (negative regulation of cell aging) 54.55%
- [GO:0080134](http://purl.obolibrary.org/obo/GO_0080134) (regulation of response to stress) and [GO:0090344](http://purl.obolibrary.org/obo/GO_0090344) (negative regulation of cell aging) 54.55%
- [GO:0051093](http://purl.obolibrary.org/obo/GO_0051093) (negative regulation of developmental process) and [GO:2000772](http://purl.obolibrary.org/obo/GO_2000772) (regulation of cellular senescence) 54.55%
- [GO:0051093](http://purl.obolibrary.org/obo/GO_0051093) (negative regulation of developmental process) and [GO:0090342](http://purl.obolibrary.org/obo/GO_0090342) (regulation of cell aging) 54.55%


